ClinicalTrials.gov
public full text
Public Domain
A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa
Approximately 42 HIV-negative women, aged \>18 and \< 50, will be enrolled in this study. Each volunteer will have a 2:1 chance of receiving Dapivirine Gel-002 versus placebo. The volunteers will receive investigational product for a total of 42 days.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium#830095
- Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans#849922
- Data for: "Proof-of-concept trial of electronic monitoring devices for adolescents living with HIV in Zimbabwe"#452314
- Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers#828343
- Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert#881539
Record · ID 1071974
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive